Kidney cancer in the Middle East and North Africa region: a 30-year analysis (1990-2019).
Epidemiology
Incidence
Kidney neoplasms
MENA
Years lived with disability
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 Jun 2024
14 Jun 2024
Historique:
received:
21
08
2023
accepted:
10
06
2024
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
14
6
2024
Statut:
epublish
Résumé
Kidney cancer, a type of urogenital cancer, imposes a high burden on patients. Despite this, no recent research has evaluated the burden of this type of cancer in the Middle East and North Africa (MENA) region. This study explored the burden of kidney cancer from 1990 to 2019 according to age, sex and socio-demographic index (SDI). The Global Burden of Disease (GBD) 2019 data was utilized to estimate the incidence, death, and disability-adjusted life-years (DALYs) caused by kidney cancer. These estimates were reported as counts and as age-standardised rates with 95% uncertainty intervals (UIs). The estimated age-standardised incidence, mortality, and DALY rates of kidney cancer in 2019 were 3.2 (2.8-3.6), 1.4 (1.2-1.6), and 37.2 (32.0-42.6) per 100,000, respectively. Over the period from 1990 to 2019, these rates have increased by 98.0%, 48.9%, and 37.7%, respectively. In 2019, the United Arab Emirates, Qatar, and Lebanon had the largest age-standardised incidence, mortality, and DALY rates. The smallest age-standardised incidence rates were seen in Yemen, Afghanistan, and the Syrian Arab Republic. Additionally, the smallest age-standardised mortality and DALY rates were observed in the Syrian Arab Republic, Yemen, and Morocco. The highest incidence rates were found among individuals aged 75-79 in both males and females. In 2019, the MENA/Global DALY ratio exceeded one for females aged 5-19 age and males aged 5-14, compared to 1990age groups in males. The burden of kidney cancer consistently rose with increasing SDI levels from 1990 to 2019. The increasing burden of kidney cancer highlights the urgent need for interventions aimed at improving early diagnosis and treatment in the region.
Identifiants
pubmed: 38877130
doi: 10.1038/s41598-024-64521-7
pii: 10.1038/s41598-024-64521-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13710Subventions
Organisme : Shahid Beheshti University of Medical Sciences
ID : 43004455
Informations de copyright
© 2024. The Author(s).
Références
Collaboration GBoDC. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncol. 8(3), 420–44 (2022).
doi: 10.1001/jamaoncol.2021.6987
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71(3), 209–49 (2021).
pubmed: 33538338
Scelo, G. & Larose, T. L. Epidemiology and risk factors for kidney cancer. J. Clin. Oncol. 36(36), 2018791905 (2018).
doi: 10.1200/JCO.2018.79.1905
Rini, B. I., Campbell, S. C. & Escudier, B. Renal cell carcinoma. The Lancet 373(9669), 1119–1132 (2009).
doi: 10.1016/S0140-6736(09)60229-4
Lang, K., Danchenko, N., Gondek, K., Schwartz, B. & Thompson, D. The burden of illness associated with renal cell carcinoma in the United States. Urol. Oncol. 25(5), 368–375 (2007).
doi: 10.1016/j.urolonc.2007.02.014
pubmed: 17826652
Bai, X., Yi, M., Dong, B., Zheng, X. & Wu, K. The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Exp. Hematol. Oncol. 9(1), 1–15 (2020).
doi: 10.1186/s40164-020-00181-3
Zi, H. et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Milit. Med. Res. 8(1), 1–15 (2021).
Safiri, S. et al. The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017. Sci. Rep. 10(1), 1–20 (2020).
doi: 10.1038/s41598-020-70840-2
Jani, C. et al. Trends of kidney cancer burden from 1990 to 2019 in European Union 15+ countries and World Health Organization regions. Sci. Rep. 12(1), 22368 (2022).
doi: 10.1038/s41598-022-25485-8
pubmed: 36572700
pmcid: 9792551
Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet 396(10258), 1204–1222 (2020).
doi: 10.1016/S0140-6736(20)30925-9
Murray, C. J. L. et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet 396(10258), 1223–1249 (2020).
doi: 10.1016/S0140-6736(20)30752-2
Wang, H. et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet 396(10258), 1160–1203 (2020).
doi: 10.1016/S0140-6736(20)30977-6
Wang, Y. Smoothing Splines: Methods and applications (Chapman and Hall/CRC, 2019).
Wong, M. C. S. et al. Incidence and mortality of kidney cancer: Temporal patterns and global trends in 39 countries. Sci. Rep. 7(1), 15698 (2017).
doi: 10.1038/s41598-017-15922-4
pubmed: 29146923
pmcid: 5691143
Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W. & Charbonneau, C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review. Cancer Treat. Rev. 34(3), 193–205 (2008).
doi: 10.1016/j.ctrv.2007.12.001
pubmed: 18313224
McCredie, M. & Stewart, J. H. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 3(4), 323–31 (1992).
doi: 10.1007/BF00146885
pubmed: 1617119
Chow, W.-H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 7(5), 245–257 (2010).
doi: 10.1038/nrurol.2010.46
pubmed: 20448658
pmcid: 3012455
Mills, K. T., Stefanescu, A. & He, J. The global epidemiology of hypertension. Nat. Rev. Nephrol. 16(4), 223–237 (2020).
doi: 10.1038/s41581-019-0244-2
pubmed: 32024986
pmcid: 7998524
Mills, K. T. et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation 134(6), 441–450 (2016).
doi: 10.1161/CIRCULATIONAHA.115.018912
pubmed: 27502908
pmcid: 4979614
Nam, G. E. et al. Obesity, abdominal obesity and subsequent risk of kidney cancer: A cohort study of 2.33 million East Asians. Br. J. Cancer 121(3), 271–7 (2019).
doi: 10.1038/s41416-019-0500-z
pubmed: 31231120
pmcid: 6738324
World Health Organization. Prevalence of Obesity Among Adults, Both Sex 2016. http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/obesity/atlas.html .
Blüher, M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15(5), 288–298 (2019).
doi: 10.1038/s41574-019-0176-8
pubmed: 30814686
Hunt, J. D., van der Hel, O. L., McMillan, G. P., Boffetta, P. & Brennan, P. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int. J. Cancer 114(1), 101–108 (2005).
doi: 10.1002/ijc.20618
pubmed: 15523697
Tsivian, M., Moreira, D. M., Caso, J. R., Mouraviev, V. & Polascik, T. J. Cigarette smoking is associated with advanced renal cell carcinoma. J. Clin. Oncol. 29(15), 2027–2031 (2011).
doi: 10.1200/JCO.2010.30.9484
pubmed: 21502558
Dai, X., Gakidou, E. & Lopez, A. D. Evolution of the global smoking epidemic over the past half century: Strengthening the evidence base for policy action. Tob. Control 31(2), 129–137 (2022).
doi: 10.1136/tobaccocontrol-2021-056535
pubmed: 35241576
Kabat, G., Silvera, S., Miller, A. & Rohan, T. A cohort study of reproductive and hormonal factors and renal cell cancer risk in women. Br. J. Cancer 96(5), 845–849 (2007).
doi: 10.1038/sj.bjc.6603629
pubmed: 17311018
pmcid: 2360073
Lambe, M., Lindblad, P., Wuu, J., Remler, R. & Hsieh, C. Pregnancy and risk of renal cell cancer: A population-based study in Sweden. Br. J. Cancer 86(9), 1425–1429 (2002).
doi: 10.1038/sj.bjc.6600263
pubmed: 11986775
pmcid: 2375385
Manthey, J. et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: A modelling study. Lancet 393(10190), 2493–2502 (2019).
doi: 10.1016/S0140-6736(18)32744-2
pubmed: 31076174
Ziouziou, I., Shariat, S. F., Ajdi, F. & Khabbal, Y. Association of processed meats and alcohol consumption with renal cell carcinoma: A worldwide population-based study. Nutr. Cancer 73(11–12), 2665–2670 (2021).
doi: 10.1080/01635581.2020.1856388
pubmed: 33283531
Huang, J. et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur. Urol. Focus 8(1), 200–9 (2022).
doi: 10.1016/j.euf.2020.12.020
pubmed: 33495133